Peritoneal cell culture: Fibroblasts

Peritoneal Dialysis International

Volumn 26, Issue 3, 2006, Pages 292-299

  Witowski, Janusz ^a   Jörres, Achim ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cell culture; Fibroblast; Peritoneum

Indexed keywords

CELL HETEROGENEITY; CELL SUBPOPULATION; CELL TYPE; CONTROLLED STUDY; FIBROBLAST; FIBROBLAST CULTURE; FIBROSIS; HUMAN; HUMAN CELL; INFLAMMATION; NEOPLASM; PATHOPHYSIOLOGY; PERITONEAL DISEASE; PERITONEUM CELL; PRIORITY JOURNAL; REVIEW;

EID: 33748432434     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600302     Document Type: Review

References (50)

1. Chang HY, Chi JT, Dudoit S, Bondre C, van de RM, Botstein D, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002; 99: 12877-82.
2. Xia Y, Pauza ME, Feng L, Lo D. RelB regulation of chemokine expression modulates local inflammation. Am J Pathol 1997; 151:375-87.
3. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303:848-51.
4. Silzle T, Randolph GJ, Kreutz M, Kunz-Schughart LA. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 2004; 108:173-80.
5. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 2001; 98:12072-7.
6. Schuler T, Kornig S, Blankenstein T. Tumor rejection by modulation of tumor stromal fibroblasts. J Exp Med 2003; 198:1487-93.
7. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001; 166:7556-62.
8. Ishii G, Sangai T, Sugiyama K, Ito T, Hasebe T, Endoh Y, et al. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells 2005; 23:699-706.
9. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-84.
10. del Peso G, Jimenez-Heffernan JA, Bajo MA, Hevia C, Aguilera A, Castro MJ, et al. Myofibroblastic differentiation in simple peritoneal sclerosis. Int J Artif Organs 2005; 28:135-40.
11. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348:403-13.
12. Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, West-Mays JA, et al. Transient overexpression of TGF-{beta} 1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005; 16:425-36.
13. Yang AH, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int 2003; 63:1530-9.
14. Aroeira LS, Aguilera A, Selgas R, Ramirez-Huesca M, Perez-Lozano ML, Cirugeda A, et al. Mesenchymal conversion of mesothelial cell as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 2005; 46: 938-48.
15. Jörres A, Ludat K, Lang J, Sander K, Gahl GM, Frei U, et al. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines. J Am Soc Nephrol 1996; 7:2192-201.
16. Beavis MJ, Williams JD, Hoppe J, Topley N. Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int 1997; 51:205-15.
17. Lang MJ, Topley N. Isolation, culture and characterisation of human peritoneal mesothelial cells. In: Doyle A, Griffiths JP, Newell DG, eds. Cell and Tissue Culture Manual: Specialized Vertebrate Cultures-Integumentary Systems and Muscular Tissue. Cirencester, UK:John Wiley; 1998: 10.11-10.13.
18. Gilbert SF, Migeon BR. D-Valine as a selective agent for normal human and rodent epithetial cells in culture. Cell 1975; 5:11-17.
19. Saed GM, Zhang W, Diamond MP. Molecular characterization of fibroblasts isolated from human peritoneum and adhesions. Fertil Steril 2001; 75:763-8.
20. Amari M, Taguchi K, Iwahara M, Shibuya K, Naoe S. Immunohistochemical and ultrastructural study on effect of fibroblast growth factor on transformation of fibroblasts to regenerated mesothelial cells. Med Electron Microsc 2002; 35:225-33.
21. Takezawa T, Mori Y, Yonaha T, Yoshizato K. Characterization of morphology and cellular metabolism during the spheroid formation by fibroblasts. Exp Cell Res 1993; 208: 430-41.
22. Amari M, Taguchi K, Iwahara M, Naoe S, Takahasi K. Immunohistochemical and ultrastructural studies of the effects of prednisolone on transformation of fibroblast to regenerated mesothelial cells. Med Electron Microsc 2004; 37:242-51.
23. Leavesley DI, Stanley JM, Faull RJ. Epidermal growth factor modifies the expression and function of extracellular matrix adhesion receptors expressed by peritoneal mesothelial cells from patients on CAPD. Nephrol Dial Transplant 1999; 14:1208-16.
24. Miettinen M, Kovatich AJ. HMBE-1 a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft-tissue and bone tumors. Appl Immunohistochem 1995; 3: 115-22.
25. Connell ND, Rheinwald JG. Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 1983; 34: 245-53.
26. LaRocca PJ, Rheinwald JG. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. Cancer Res 1984; 44: 2991-9.
27. Zhang XY, Pettengell R, Nasiri N, Kalia V, Dalgleish AG, Barton DP. Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithetial ovarian cancer and non-ovarian cancer sources. J Soc Gynecol Investig 1999; 6:333-40.
28. Okada H, Inoue T, Kanno Y, Kobayashi T, Watanabe Y, Kopp JB, et al. Interstitial fibroblast-like cells express reninangiotensin system components in a fibrosing murine kidney. Am J Pathol 2002; 160:765-72.
29. Fetsch PA, Simsir A, Abati A. Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology. Diagn Cytopathol 2001; 25: 158-61.
30. Politi E, Kandaraki C, Apostolopoulou C, Kyritsi T, Koutselini H. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Diagn Cytopathol 2005; 32:151-5.
31. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130:393-405.
32. Ji J, Zhao L, Wang X, Zhou C, Ding F, Su L, et al. Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004; 130:480-6.
33. Okada H, Inoue T, Kanno Y, Kobayashi T, Watanabe Y, Ban S, et al. Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome. Kidney Int 2003; 64:1722-32.
34. Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol 2003; 163:1291-300.
35. Koumas L, King AE, Critchley HO, Kelly RW, Phipps RP. Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts. Am J Pathol 2001; 159:925-35.
36. Zhou Y, Hagood JS, Murphy-Ullrich JE. Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol 2004; 165:659-69.
37. Nissi R, Autio-Harmainen H, Marttila P, Sormunen R, Kivirikko KI. Prolyl 4-hydroxylase isoenzymes I and II have different expression patterns in several human tissues. J Histochem Cytochem 2001; 49:1143-53.
38. Auersperg N, Maines-Bandiera SL, Dyck HG, Kruk PA. Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Lab Invest 1994; 71:510-18.
39. Witowski J, Thiel A, Dechend R, Dunkel K, Fouquet N, Bender TO, et al. Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts: induction by macrophage-derived cytokines. Am J Pathol 2001; 158:1441-50.
40. Topley N, Petersen MM, Mackenzie R, Neubauer A, Stylianou E, Kaever V, et al. Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int 1994; 46:900-9.
41. Saed GM, Munkarah AR, Diamond MP. Cyclooxygenase-2 is expressed in human fibroblasts isolated from intraperitoneal adhesions but not from normal peritoneal tissues. Fertil Steril 2003; 79:1404-8.
42. Diamond MP, El Hammady E, Munkarah A, Bieber EJ, Saed G. Modulation of the expression of vascular endothelial growth factor in human fibroblasts. Fertil Steril 2005; 83: 405-9.
43. Saed GM, Munkarah AR, Abu-Soud HM, Diamond MP. Hypoxia upregulates cyclooxygenase-2 and prostaglandin E(2) levels in human peritoneal fibroblasts. Fertil Steril 2005; 83(Suppl 1):1216-19.
44. Jörres A, Bender TO, Finn A, Witowski J, Frohlich S, Gahl GM, et al. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int 1998; 54:2184-93.
45. Breborowicz A, Martis L, Oreopoulos DG. In vitro influence of lactate on function of peritoneal fibroblasts. Adv Perit Dial 1994; 10:225-9.
46. Breborowicz A, Martis L, Oreopoulos DG. Changes in biocompatibility of dialysis fluid during its dwell in the peritoneal cavity. Perit Dial Int 1995; 15:152-7.
47. Ogata S, Yorioka N, Kohno N. Glucose and prednisolone alter basic fibroblast growth factor expression in peritoneal mesothelial cells and fibroblasts. J Am Soc Nephrol 2001; 12:2787-96.
48. Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991;40:77-9.
49. Teta D, Tedjani A, Burnier M, Bevington A, Brown J, Harris K. Glucose-containing peritoneal dialysis fluids regulate leptin secretion from 3T3-L1 adipocytes. Nephrol Dial Transplant 2005; 20:1329-35.
50. Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4):S19-29.